Sort by
Refine Your Search
-
cytotoxic payloads (Trastuzumab Deruxtecan and Trastuzumab Emtansine). These models will allow us to explore how payload differences influence both tumor cell killing and immune modulation within the TME. In
-
interdisciplinary research team. We study tumor evolution and immune microenvironment adaptation by combining functional genomics, experimental model systems, patient samples, and computational biology (Brägelmann et
-
The Max Delbrück Center for Molecular Medicine in the Helmholtz Association aims to transform tomorrow’s medicine through our discoveries of today. At locations in Berlin-Buch, Berlin-Mitte
-
damage are responsible for many of the mutations that cause cancer and treatment resistance. But their dynamics, the molecular machinery involved, and their role in disease are still poorly understood
-
: 01.10.2025 Application deadline: 03.09.2025 Tasks Execution of experimental work in a mouse model of cortical multiple sclerosis Application of in vivo imaging and quantitative analysis methods Investigation
-
Reference Number: 11180 Fixed-term of 3 years | Part-time with 65% (25 hours/week) | Salary according to TV-L EG13 | European Institute for Molecular Imaging We are UKM. We have a clear social
-
presentations Your Profile: • Master's degree (or equivalent) in immunology, biology, molecular biology, or a related field • Prior experience with flow cytometry, immunological assays, or molecular biology
-
, 65 %). The Institute of Pharmacology focuses on deciphering the molecular mechanisms that control regeneration as well as tumor initiation and progression in epithelial tissues (https://www.uni
-
! RESPONSIBILITIES: You will elucidate the molecular mechanisms driving the development of distinct malignant lymphoma subtypes and contribute to the identification of predictive biomarkers and novel therapeutic
-
, to experimental biophysics and biochemistry, and, to cell and molecular biology involving data science. A position comprises 65-75 % of the fulltime weekly hours and is limited until March 31, 2030. The period of